MRK
NYSEStockMerck & Co., Inc.
$116.40+0.24 (+0.21%)
52-Week Range
$73.47
$123.82
Key Stats
Market Cap
287.8B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.26
Volume
4.9M
Avg Volume
10.4M
Performance
1M
-1.06%
3M
+15.56%
6M
+43.06%
YTD
+8.89%
1Y
+24.17%
3Y
+8.36%
5Y
+52.05%
Price Chart
ETF Exposure
MRK is held by 481 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PPH | VanEck Pharmaceutical ETF | 9.61% |
| DJD | Invesco Dow Jones Industrial Average Dividend ETF | 8.66% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 8.18% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 5.88% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 5.87% |
| FLAG | Global X - S&P 500 U.S. Market Leaders Top 50 ETF | 5.75% |
| TINT | ProShares - Smart Materials ETF | 5.70% |
| FDL | First Trust Morningstar Dividend Leaders Index Fund | 5.53% |
| XLV | State Street Health Care Select Sector SPDR ETF | 5.24% |
| DURA | VanEck Durable High Dividend ETF | 5.14% |
| IYH | iShares U.S. Healthcare ETF | 5.13% |
| IHE | iShares U.S. Pharmaceuticals ETF | 5.07% |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 5.05% |
| PALC | Pacer Lunt Large Cap Multi-Factor Alternator ETF | 5.04% |
| SYE | SPDR MFS Systematic Core Equity ETF | 5.01% |
| PJP | Invesco Pharmaceuticals ETF | 4.96% |
| VFLO | VictoryShares Free Cash Flow ETF | 4.78% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 4.74% |
| DOGG | FT Vest DJIA Dogs 10 Target Income ETF | 4.73% |
| JDOC | JPMorgan Healthcare Leaders ETF | 4.69% |
| BAMV | Brookstone Value Stock ETF | 4.55% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 4.50% |
| PAWZ | ProShares - Pet Care ETF | 4.41% |
| HDIV | QRAFT AI-Enhanced U.S. High Dividend ETF | 4.32% |
| BMED | iShares Health Innovation Active ETF | 4.25% |
| VHT | Vanguard Health Care ETF | 4.20% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 4.16% |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 4.16% |
| SCHD | Schwab U.S. Dividend Equity ETF | 4.13% |
| DHS | WisdomTree U.S. High Dividend Fund | 4.00% |
| EDOW | First Trust Dow 30 Equal Weight ETF | 3.92% |
| FMK | First Trust Mega Cap AlphaDEX Fund | 3.92% |
| RXL | ProShares - Ultra Health Care | 3.90% |
| MEDX | Horizon Kinetics Medical ETF | 3.88% |
| GBDV | Global Beta Smart Income ETF | 3.76% |
| AGNG | Global X - Aging Population ETF | 3.53% |
| RSMV | Relative Strength Managed Volatility Strategy ETF | 3.48% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.37% |
| CANC | Tema Oncology ETF | 3.37% |
| SPHQ | Invesco S&P 500 Quality ETF | 3.20% |
| VLLU | Harbor AlphaEdge Large Cap Value ETF (VLLU) | 3.05% |
| DIVO | Amplify CWP Enhanced Dividend Income ETF | 3.04% |
| OUSA | ALPS Funds O’Shares U.S. Quality Dividend ETF | 2.97% |
| JHMH | John Hancock Multifactor Health Care ETF | 2.84% |
| SELV | SEI Enhanced Low Volatility U.S. Large Cap ETF | 2.80% |
| BUSA | Brandes U.S. Value ETF | 2.78% |
| DSTL | Distillate U.S. Fundamental Stability & Value ETF | 2.65% |
| RAFE | PIMCO RAFI ESG U.S. ETF | 2.62% |
| INCE | Franklin Income Equity Focus ETF | 2.60% |
| PEXL | Pacer US Export Leaders ETF | 2.58% |
Page 1 of 10Next
About MRK ETF Exposure
Merck & Co., Inc. (MRK) is held by 481 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 287.8B, MRK is a widely held institutional stock. The stock currently trades at $116.40. Investors can gain exposure to MRK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MRK, sorted by portfolio weight.